Tumor:normal fold change for expression of 396 miRNAs in 30 ESCC cases. (XLS 283 kb
Full list of genes associated with EMT which could be potentially regulated by miR-148a or miR-625-3...
Table S1. miRNAs differentialy expressed in NPC versus control. Table S2. The top 20 most significan...
Table S5. Association between lymphatic progression and clinicopathological characteristics in ESCC ...
Tumor:normal expression fold changes for miRNAs and 35 target gene mRNAs in 30 ESCC cases. (XLS 120 ...
Expression of miRNAs (n = 60) and targeted genes (n = 32) in ESCC cases (n = 30) by biallelic loss s...
miRNA and targeted gene tumor:normal expression fold changes (70 miRNAs, 35 genes, 30 ESCC cases). (...
The genes targeted by downregulated miRNAs. Table S2. The genes targeted by upregulated miRNAs. (XLS...
The relationship between the expression of the 20 miRNAs in the tumors (T/N ratio) and clinicopathol...
Table S2. Univariate and multivariate analysis of ESCC patient survival following esophagectomy usin...
Table S1. Clinical characteristics of patients with ESCC in this study. Table S2. Primer sequences f...
Table S3. TCGA tissue microRNAs differentially expressed for TNBC versus DPBC cancers (fold change ≤...
Table S3. Association between plasma miR-655 levels and clinicopathological characteristics in ESCC ...
Table S4. Association between plasma miR-655 levels and clinicopathological characteristics in ESCC ...
Table S1. TCGA tissue microRNAs differentially expressed for TNBC versus normal tissue (fold change ...
Microarray data providing the expression matrix and normalization values for samples of Batch I, Bat...
Full list of genes associated with EMT which could be potentially regulated by miR-148a or miR-625-3...
Table S1. miRNAs differentialy expressed in NPC versus control. Table S2. The top 20 most significan...
Table S5. Association between lymphatic progression and clinicopathological characteristics in ESCC ...
Tumor:normal expression fold changes for miRNAs and 35 target gene mRNAs in 30 ESCC cases. (XLS 120 ...
Expression of miRNAs (n = 60) and targeted genes (n = 32) in ESCC cases (n = 30) by biallelic loss s...
miRNA and targeted gene tumor:normal expression fold changes (70 miRNAs, 35 genes, 30 ESCC cases). (...
The genes targeted by downregulated miRNAs. Table S2. The genes targeted by upregulated miRNAs. (XLS...
The relationship between the expression of the 20 miRNAs in the tumors (T/N ratio) and clinicopathol...
Table S2. Univariate and multivariate analysis of ESCC patient survival following esophagectomy usin...
Table S1. Clinical characteristics of patients with ESCC in this study. Table S2. Primer sequences f...
Table S3. TCGA tissue microRNAs differentially expressed for TNBC versus DPBC cancers (fold change ≤...
Table S3. Association between plasma miR-655 levels and clinicopathological characteristics in ESCC ...
Table S4. Association between plasma miR-655 levels and clinicopathological characteristics in ESCC ...
Table S1. TCGA tissue microRNAs differentially expressed for TNBC versus normal tissue (fold change ...
Microarray data providing the expression matrix and normalization values for samples of Batch I, Bat...
Full list of genes associated with EMT which could be potentially regulated by miR-148a or miR-625-3...
Table S1. miRNAs differentialy expressed in NPC versus control. Table S2. The top 20 most significan...
Table S5. Association between lymphatic progression and clinicopathological characteristics in ESCC ...